Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non–small-cell lung cancer FR Hirsch, M Varella-Garcia, PA Bunn Jr, WA Franklin, R Dziadziuszko, ... Journal of clinical oncology 24 (31), 5034-5042, 2006 | 921 | 2006 |
Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development HM Arthur, J Ure, AJH Smith, G Renforth, DI Wilson, E Torsney, ... Developmental biology 217 (1), 42-53, 2000 | 609 | 2000 |
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. LD Buttery, DR Springall, AH Chester, TJ Evans, EN Standfield, ... Laboratory investigation; a journal of technical methods and pathology 75 (1 …, 1996 | 543 | 1996 |
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. DV Parums, JL Cordell, K Micklem, AR Heryet, KC Gatter, DY Mason Journal of clinical pathology 43 (9), 752-757, 1990 | 531 | 1990 |
Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. DV Parums, DL Brown, MJ Mitchinson Archives of pathology & laboratory medicine 114 (4), 383-387, 1990 | 393 | 1990 |
The spectrum of chronic periaortitis DV Parums Histopathology 16 (5), 423-431, 1990 | 212 | 1990 |
Inducible expression of human endoglin during inflammation and wound healing in vivo E Torsney, R Charlton, D Parums, M Collis, HM Arthur Inflammation Research 51, 464-470, 2002 | 203 | 2002 |
The distribution of adhesion molecules in human atherosclerosis KM Wood, MD Cadogan, AL Ramshaw, DV Parums Histopathology 22 (5), 437-444, 1993 | 184 | 1993 |
Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis N Ray-Chaudhuri, DA Kine, SO Tijani, DV Parums, N Cartlidge, ... British Journal of Ophthalmology 86 (5), 530-532, 2002 | 148 | 2002 |
The localisation of immunoglobulin in chronic periaortitis DV Parums, DR Chadwick, MJ Mitchinson Atherosclerosis 61 (2), 117-123, 1986 | 145 | 1986 |
Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines DV Parums Medical science monitor: international medical journal of experimental and …, 2021 | 143 | 2021 |
Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaques D Parums, MJ Mitchinson Atherosclerosis 38 (1-2), 211-216, 1981 | 132 | 1981 |
Revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2 DV Parums Medical science monitor: international medical journal of experimental and …, 2021 | 102 | 2021 |
Epidermal growth factor receptor immunohistochemistry: Comparison of antibodies and cutoff points to predict benefit from gefitinib in a phase 3 placebo‐controlled study in … FR Hirsch, R Dziadziuszko, N Thatcher, H Mann, C Watkins, DV Parums, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 99 | 2008 |
Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis AL Ramshaw, DV Parums Histopathology 17 (6), 543-552, 1990 | 94 | 1990 |
Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). AL Ramshaw, DE Roskell, DV Parums Journal of clinical pathology 47 (8), 721-727, 1994 | 93 | 1994 |
Current status of oral antiviral drug treatments for SARS-CoV-2 infection in non-hospitalized patients DV Parums Medical science monitor: international medical journal of experimental and …, 2022 | 88 | 2022 |
Long COVID, or post-COVID syndrome, and the global impact on health care DV Parums Medical science monitor: international medical journal of experimental and …, 2021 | 87 | 2021 |
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake D Pagano, JN Townend, DV Parums, RS Bonser, PG Camici Heart 83 (4), 456-461, 2000 | 86 | 2000 |
The xbb. 1.5 (‘kraken’) subvariant of omicron sars-cov-2 and its rapid global spread DV Parums Medical science monitor: international medical journal of experimental and …, 2023 | 77 | 2023 |